SARS-CoV-2 IgG/IgM Rapid Qualitative Test
INNOVA Medical Group
Authorized for the detection of SARS-CoV-2 antibodies, these lateral flow tests require one drop of blood and provide a colorimetric readout in only 10 minutes.
Antibody testing, also known as serology testing, determines if one had COVID-19 in the past and has now recovered. The INNOVA Antibody test is a machine-free, diagnostic lateral flow test. With a painless prick to the finger, a drop of blood is released onto a cartridge to evaluate for the presence of COVID-19 specific IgG and IgM. The test targets the nucleocapside protein as well as the spike protein. A patient’s immune system produced these protein antibodies to fight and clear out the SARS-CoV-2 virus.
Timing is key in administering this qualitative diagnostic test as if the procedure is done too early in the course of infection, the immune response may have not built up enough antibodies to detect. That is why medical personnel recommend not testing until at least 14 days after the onset of COVID-19 symptoms.
As the coronavirus is new, the level and length of immunity from future infections is not yet known. The INNOVA antibody test can determine who had COVID-19 and recovered, including those asymptomatic people who never had any symptoms. Besides rapid antigen tests, the antibody test can help determine if individuals can return to the workforce without risk of being infected and infecting others. Analyzing these tests can assist epidemiologists and public health personnel to better understand disease spread.
They provide a clearer look at disease exposure and risk of future outbreaks in the community. Most importantly, people who have recovered may be able to donate a part of their blood, called convalescent plasma, which can boost the ability for others to fight the virus.